HEADER ANTIMICROBIAL PROTEIN 02-AUG-12 2LWL TITLE STRUCTURAL BASIS FOR THE INTERACTION OF HUMAN β-DEFENSIN 6 AND TITLE 2 ITS PUTATIVE CHEMOKINE RECEPTOR CCR2 AND BREAST CANCER MICROVESICLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-DEFENSIN 106; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BETA-DEFENSIN 6, BD-6, DEFB-6, DEFENSIN, BETA 106; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DEFB106A, BD6, DEFB106, DEFB6, DEFB106B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS BREAST CANCER, DYNAMIC, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR V.S.DE PAULA,N.S.F.GOMES,L.G.LIMA,C.A.MIYAMOTO,R.Q.MONTEIRO, AUTHOR 2 F.C.L.ALMEIDA,A.VALENTE REVDAT 3 13-NOV-13 2LWL 1 JRNL REVDAT 2 11-SEP-13 2LWL 1 JRNL REVDAT 1 21-AUG-13 2LWL 0 JRNL AUTH V.S.DE PAULA,N.S.GOMES,L.G.LIMA,C.A.MIYAMOTO,R.Q.MONTEIRO, JRNL AUTH 2 F.C.ALMEIDA,A.P.VALENTE JRNL TITL STRUCTURAL BASIS FOR THE INTERACTION OF HUMAN BETA-DEFENSIN JRNL TITL 2 6 AND ITS PUTATIVE CHEMOKINE RECEPTOR CCR2 AND BREAST CANCER JRNL TITL 3 MICROVESICLES. JRNL REF J.MOL.BIOL. V. 425 4479 2013 JRNL REFN ISSN 0022-2836 JRNL PMID 23938203 JRNL DOI 10.1016/J.JMB.2013.08.001 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA/CNS VERSION 1.2 REMARK 3 AUTHORS : NILGES, M. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LWL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-AUG-12. REMARK 100 THE RCSB ID CODE IS RCSB102922. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.0 REMARK 210 IONIC STRENGTH : 5 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.6 MM [U-99% 13C; U-99% 15N] REMARK 210 SODIUM PHOSPHATE, 0.2-0.6 MM [U- REMARK 210 99% 15N] SODIUM PHOSPHATE, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-13C NOESY; 3D 1H-15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 10 30.47 70.97 REMARK 500 1 ASN A 20 17.25 58.28 REMARK 500 1 SER A 40 -47.18 80.77 REMARK 500 1 ILE A 43 -114.57 38.48 REMARK 500 2 ILE A 43 -15.09 78.22 REMARK 500 2 ILE A 44 -51.27 -144.17 REMARK 500 3 SER A 42 -177.29 69.04 REMARK 500 3 ILE A 43 -61.96 73.77 REMARK 500 3 ILE A 44 148.51 -170.18 REMARK 500 4 SER A 42 123.39 69.19 REMARK 500 4 ILE A 43 132.08 76.99 REMARK 500 4 ILE A 44 97.28 44.15 REMARK 500 5 SER A 40 -2.78 74.77 REMARK 500 5 ILE A 43 -42.38 76.44 REMARK 500 6 ILE A 37 99.93 -62.19 REMARK 500 6 PRO A 39 146.51 -38.21 REMARK 500 6 SER A 42 165.15 72.37 REMARK 500 6 ILE A 43 -74.48 68.89 REMARK 500 7 SER A 40 -145.27 -135.06 REMARK 500 7 SER A 42 -144.80 60.51 REMARK 500 7 ILE A 43 -82.57 -79.86 REMARK 500 8 ILE A 43 -66.23 71.70 REMARK 500 9 SER A 42 -171.77 65.46 REMARK 500 9 ILE A 43 -72.10 68.99 REMARK 500 10 SER A 42 -145.03 62.71 REMARK 500 11 SER A 30 -4.20 80.97 REMARK 500 11 SER A 42 159.45 65.60 REMARK 500 11 ILE A 43 -66.68 74.32 REMARK 500 12 SER A 40 -61.64 73.64 REMARK 500 12 SER A 42 -114.60 42.01 REMARK 500 12 ILE A 43 -88.23 -140.37 REMARK 500 13 ILE A 24 -30.26 -130.93 REMARK 500 13 PRO A 39 -171.19 -58.94 REMARK 500 13 SER A 42 -168.08 55.38 REMARK 500 14 SER A 40 161.10 179.29 REMARK 500 14 SER A 42 -150.86 64.61 REMARK 500 14 ILE A 43 -78.19 75.34 REMARK 500 15 SER A 40 -167.57 -165.50 REMARK 500 15 SER A 42 80.80 39.14 REMARK 500 15 ILE A 43 -97.06 33.37 REMARK 500 16 LYS A 29 14.53 59.54 REMARK 500 16 SER A 40 165.21 70.53 REMARK 500 16 SER A 42 143.93 167.63 REMARK 500 16 ILE A 43 -57.14 70.69 REMARK 500 17 LYS A 10 43.96 71.41 REMARK 500 17 LYS A 19 109.56 -41.48 REMARK 500 17 SER A 30 -1.57 77.92 REMARK 500 17 SER A 40 123.33 72.25 REMARK 500 17 ILE A 43 -50.48 73.42 REMARK 500 18 ILE A 37 99.87 -67.73 REMARK 500 REMARK 500 THIS ENTRY HAS 56 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18634 RELATED DB: BMRB DBREF 2LWL A 1 45 UNP Q8N104 D106A_HUMAN 21 65 SEQADV 2LWL GLY A -3 UNP Q8N104 EXPRESSION TAG SEQADV 2LWL SER A -2 UNP Q8N104 EXPRESSION TAG SEQADV 2LWL HIS A -1 UNP Q8N104 EXPRESSION TAG SEQADV 2LWL MET A 0 UNP Q8N104 EXPRESSION TAG SEQADV 2LWL SER A 40 UNP Q8N104 CYS 60 ENGINEERED MUTATION SEQRES 1 A 49 GLY SER HIS MET PHE PHE ASP GLU LYS CYS ASN LYS LEU SEQRES 2 A 49 LYS GLY THR CYS LYS ASN ASN CYS GLY LYS ASN GLU GLU SEQRES 3 A 49 LEU ILE ALA LEU CYS GLN LYS SER LEU LYS CYS CYS ARG SEQRES 4 A 49 THR ILE GLN PRO SER GLY SER ILE ILE ASP HELIX 1 1 PHE A 1 LEU A 9 1 9 SHEET 1 A 3 THR A 12 LYS A 14 0 SHEET 2 A 3 LYS A 32 THR A 36 -1 O CYS A 34 N THR A 12 SHEET 3 A 3 GLU A 21 LEU A 26 -1 N ILE A 24 O CYS A 33 SSBOND 1 CYS A 6 CYS A 33 1555 1555 2.99 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1